{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:12:05Z","timestamp":1776057125603,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004017","name":"Japanese Association of Dialysis Physicians","doi-asserted-by":"publisher","award":["2023-1"],"award-info":[{"award-number":["2023-1"]}],"id":[{"id":"10.13039\/501100004017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012832","name":"Okinaka Memorial Institute for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012832","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.mayocp.2024.12.019","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:43:34Z","timestamp":1747755814000},"page":"1535-1550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Body Mass Index and Age at End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease in the United States and Japan"],"prefix":"10.1016","volume":"100","author":[{"given":"Tatsuya","family":"Suwabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2008-1576","authenticated-orcid":false,"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa E.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuck D.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichiro","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Hanafusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10174","key":"10.1016\/j.mayocp.2024.12.019_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"issue":"9981","key":"10.1016\/j.mayocp.2024.12.019_bib2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet"},{"issue":"9569","key":"10.1016\/j.mayocp.2024.12.019_bib3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mayocp.2024.12.019_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2215\/CJN.16871020","article-title":"Overweight and obesity and progression of ADPKD","volume":"16","author":"Nowak","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.mayocp.2024.12.019_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1681\/ASN.2017070819","article-title":"Overweight and obesity are predictors of progression in early autosomal dominant polycystic kidney disease","volume":"29","author":"Nowak","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.mayocp.2024.12.019_bib6","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.00551.2015","article-title":"A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease","volume":"310","author":"Kipp","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.mayocp.2024.12.019_bib7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease","volume":"27","author":"Warner","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2024.12.019_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103697","article-title":"Weight loss and cystic disease progression in autosomal dominant polycystic kidney disease","volume":"25","author":"Hopp","year":"2022","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.mayocp.2024.12.019_bib9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","article-title":"Ketosis ameliorates renal cyst growth in polycystic kidney disease","volume":"30","author":"Torres","year":"2019","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.mayocp.2024.12.019_bib10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2215\/CJN.0000000000000326","article-title":"Polycystic kidney disease diet: what is known and what is safe","volume":"19","author":"Chebib","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9765","key":"10.1016\/j.mayocp.2024.12.019_bib11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants","volume":"377","author":"Finucane","year":"2011","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.mayocp.2024.12.019_bib13","first-page":"1","article-title":"Anthropometric reference data for children and adults: United States, 2015-2018","author":"Fryar","year":"2021","journal-title":"Vital Health Stat 3"},{"issue":"20","key":"10.1016\/j.mayocp.2024.12.019_bib15","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.mayocp.2024.12.019_bib16","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","article-title":"Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group","volume":"5","author":"Klahr","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.mayocp.2024.12.019_bib17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s10157-021-02059-y","article-title":"Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort study","volume":"25","author":"Hoshino","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.mayocp.2024.12.019_bib18","article-title":"Ministry of Health, Labour and Welfare (Japan)","year":"2015","journal-title":"National Health and Nutrition Survey"},{"key":"10.1016\/j.mayocp.2024.12.019_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fnut.2020.00076","article-title":"Age and racial\/ethnic differences in dietary sources of protein, NHANES, 2011-2016","volume":"7","author":"Beasley","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.mayocp.2024.12.019_bib20","first-page":"1","article-title":"Fast food consumption among adults in the United States, 2013-2016","volume":"322","author":"Fryar","year":"2018","journal-title":"NCHS Data Brief"},{"issue":"1","key":"10.1016\/j.mayocp.2024.12.019_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S136898001200122X","article-title":"What's on the menu? A review of the energy and nutritional content of US chain restaurant menus","volume":"16","author":"Wu","year":"2013","journal-title":"Public Health Nutr"},{"issue":"3","key":"10.1016\/j.mayocp.2024.12.019_bib22","first-page":"211","article-title":"Fast food, race\/ethnicity, and income: a geographic analysis","volume":"27","author":"Block","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.mayocp.2024.12.019_bib24","author":"Immad"},{"issue":"6","key":"10.1016\/j.mayocp.2024.12.019_bib27","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1681\/ASN.2005060638","article-title":"Obesity and risk for chronic renal failure","volume":"17","author":"Ejerblad","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2024.12.019_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.ajkd.2008.03.003","article-title":"Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study","volume":"52","author":"Foster","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2024.12.019_bib29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community-based population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2024.12.019_bib30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2005.06.007","article-title":"Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program","volume":"46","author":"Kramer","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2024.12.019_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0272-6386(03)00020-9","article-title":"A central body fat distribution is related to renal function impairment, even in lean subjects","volume":"41","author":"Pinto-Sietsma","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2024.12.019_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.mayocp.2024.12.019_bib33","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1523-1755.2004.00582.x","article-title":"Body mass index and the risk of development of end-stage renal disease in a screened cohort","volume":"65","author":"Iseki","year":"2004","journal-title":"Kidney Int"},{"issue":"4 pt 1","key":"10.1016\/j.mayocp.2024.12.019_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.HYP.25.4.587","article-title":"Early predictors of 15-year end-stage renal disease in hypertensive patients","volume":"25","author":"Perry","year":"1995","journal-title":"Hypertension"},{"issue":"21","key":"10.1016\/j.mayocp.2024.12.019_bib35","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/2013.jamainternmed.85","article-title":"Body mass index in 1.2 million adolescents and risk for end-stage renal disease","volume":"172","author":"Vivante","year":"2012","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.mayocp.2024.12.019_bib36","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1681\/ASN.2013070754","article-title":"Association of body mass index with outcomes in patients with CKD","volume":"25","author":"Lu","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.mayocp.2024.12.019_bib37","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa2302392","article-title":"Daily oral GLP-1 receptor agonist orforglipron for adults with obesity","volume":"389","author":"Wharton","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2024.12.019_bib38","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3390\/nu11112691","article-title":"Current sodium intakes in the United States and the modelling of glutamate's incorporation into select savory products","volume":"11","author":"Wallace","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.mayocp.2024.12.019_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.kint.2020.06.001","article-title":"Salt, water, and vasopressin in polycystic kidney disease","volume":"98","author":"Torres","year":"2020","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.mayocp.2024.12.019_bib40","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.kint.2020.04.053","article-title":"Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease","volume":"98","author":"Kramers","year":"2020","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mayocp.2024.12.019_bib41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ki.2011.157","article-title":"Smoking is a risk factor in the progression to kidney failure","volume":"80","author":"Hallan","year":"2011","journal-title":"Kidney Int"},{"issue":"24","key":"10.1016\/j.mayocp.2024.12.019_bib42","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.mayocp.2024.12.019_bib43","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624006955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624006955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T15:43:30Z","timestamp":1763307810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619624006955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0025619624006955"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2024.12.019","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Body Mass Index and Age at End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease in the United States and Japan","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2024.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}]}}